CAPRICOR THERAPEUTICS, INC. Lessee, Operating Lease, Liability, to be Paid, Year One
CAPRICOR THERAPEUTICS, INC. (CAPR) had Lessee, Operating Lease, Liability, to be Paid, Year One of $2.53 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-14
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $2.53M.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $2.41M.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $1.12M.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $1.12M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-06-30 | $2.53M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $2.41M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $1.12M 10-K · filed 2026-03-17 |
| 2025-09-30 | $1.12M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $634.89K 10-Q · filed 2025-08-11 |
| 2025-03-31 | $634.89K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $914.22K 10-K · filed 2025-03-26 |
| 2024-09-30 | $914.22K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $914.22K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $668.23K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $886.67K 10-K · filed 2024-03-11 |
| 2023-09-30 | $886.67K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $765.99K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $765.99K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $798.69K 10-K · filed 2023-03-17 |
| 2022-09-30 | $790.92K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $656.68K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $656.68K 10-Q · filed 2022-05-11 |
| 2021-12-31 | $492.38K 10-K · filed 2022-03-11 |
| 2021-09-30 | $74.95K 10-Q · filed 2021-11-12 |
| 2020-12-31 | $110.64K 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |